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Purpose: To evaluate the efficacy and safety of angle-supported phakic anterior chamber intraocular lenses 
in amblyopic adult eyes with very high myopia.
Methods: We evaluated 12 eyes in nine patients with very high myopic amblyopia who received 
angle-supported phakic intraocular lenses (Phakic 6H
Ⓡ) and followed them for more than six months. 
Uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), and complications were evaluated. A 
satisfaction score was rated by patients using a 5-point (1~5) numeric scale.
Results: The mean age of patients was 37.3±9.4 years, ranging from 29 to 59 years old. The preoperative 
mean refraction (spherical equivalent, SE) was -20.10±5.41 diopters (D). The postoperative mean refraction 
(SE) was -1.75±0.76 D at six months. The postoperative BCVA improved an average 3.92±1.24 lines over 
preoperative values, and mean endothelial cell loss was 8.9% at six months. Development of cataracts, 
glaucoma, and pupil abnormalities were not demonstrated in any case during the study. The patients were 
all very satisfied, as the average satisfaction score was 4.3.
Conclusions: This study indicates that angle-supported phakic anterior chamber intraocular lens implantation 
may be an effective surgical alternative for the correction of amblyopic adult eyes with very high myopia. 
However, long-term evaluation is necessary to assess possible complications and long-term safety.  Korean 
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The surgical correction of very high myopia currently 
includes clear lens extraction,
1,2 anterior and posterior chamber 
intraocular lens (IOL) implantation,
3,4 and keratorefractive 
surgeries such as photorefractive keratectomy (PRK), laser in 
situ keratomileusis (LASIK), and radial keratotomy.
5,6 How-
ever, clear lens extraction is associated with increased risk of 
retinal detachment, cystoid macular edema, endothelial cell 
loss, and endophthalmitis.
2,7 Keratorefractive surgeries are 
associated with iatrogenic keratectasia, significant optical 
aberrations, regression, poor quality of vision, and poor 
predictability when used to correct high myopia.
5,8-11
The implantation of phakic IOLs is an emerging tech-
nology in the treatment of high ametropia, since it avoids 
both the unpredictability of PRK and LASIK and the loss of 
accommodation of clear lens extraction.
12 Phakic IOLs have 
significant advantages such as reversibility, immediate correc-
tion, stability, and relative simplicity.
12-14 However, long-term 
studies are necessary to assess potential risks to the corneal 
endothelium, anterior uvea, and crystalline lens.
3,7 
The purpose of this study was to evaluate the efficacy, 
stability, and safety of angle-supported phakic anterior 
chamber intraocular lenses (PAC IOLs) in amblyopic adult 
eyes with very high myopia.
Materials and Methods
Angle-supported phakic IOLs (Phakic 6H
Ⓡ, Ophthalmic 
Innovations International Inc., USA) were implanted in adult 
amblyopic eyes with very high myopia between April 2001 
and August 2003 by the same surgeon (K.H.S.). Inclusion 
criteria were: age of 20 years or older, myopia of -12.0D or 
higher in spherical equivalent, a BCVA of 20/70 or worse, 
anterior chamber depth (ACD) of at least 2.8 mm, endothelial 
cell count of at least 2,500 cells/mm
2, and a wide-open angle 
(20~40 degrees) by the Shaffer’s gonioscopic classification.
15 
Exclusion criteria included glaucoma, cataract, keratoconus, 
history of uveitis, corneal dystrophy, previous ocular surgery, Korean  J  Ophthalmol  Vol.20,  No.2,  2006
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No. sex age WTW
(mm)
Previous
treatment
ACL  size
(mm)
ACL  power
(D) UCVA BSCVA 
(logMAR)
1
2
3
4
5
6
7
8
9
10
11
12
M
M
M
M
M
F
F
M
F
M
M
F
34
34
30
46
59
31
31
48
28
38
38
29
11.0
11.0
11.75
11.0
12.0
11.0
11.0
11.5
11.0
11.0
11.0
11.5
spectacle
spectacle
spectacle
spectacle
CL  (H)
spectacle
CL  (S)
spectacle
spectacle
CL  (H)
CL  (H)
CL  (S)
13
13
13
12
13
12
12
12.5
12
12
12
12.5
-25.00
-20.00
-15.00
-13.00
-19.50
-18.50
-17.00
-12.50
-14.00
-22.00
-21.00
-25.00
0.04
0.04
0.02
CF  30  cm
0.04
0.02
0.02
CF  30  cm
CF  30  cm
CF  30  cm
CF  30  cm
CF  30  cm
0.15  (0.8)
0.2  (0.7)
0.15  (0.8)
0.3  (0.5)
0.1  (1.0)
0.2  (0.7)
0.2  (0.7)
0.1  (1.0)
0.2  (0.7)
0.3  (0.5)
0.3  (0.5)
0.15  (0.8)
ACL:  anterior  chamber  IOLs,  BSCVA:  best  spectacle-corrected  visual  acuity,  CL:  contact  lens,  CF:  counting  finger,  H: 
hard  type  contact  lens,  MAR:  minimum  angle  of  resolution,  S:  soft  type  contact  lens,  UCVA:  uncorrected  visual  acuity, 
WTW:  white-to-white.
Table 1. Preoperative  evaluation  of  patients
and systemic diseases such as diabetes or hypertension, 
autoimmune diseases, and connective tissue diseases.
A preoperative ocular examination was conducted on each 
patient to evaluate distance UCVA and BCVA using a Snellen 
chart, manifest and cycloplegic refractions, Goldmann appla-
nation tonometry, keratometry, corneal topography, slit lamp 
and fundus, gonioscopy, ultrasound pachymetry, white-to- 
white (WTW) limbal dimension, endothelial cell count 
(Cellcheck CC-7000, Konan), anterior chamber depth esti-
mation by ultrasound A-scan, and pupil diameter.
All visual acuities were measured using letters on the 
Snellen chart and recorded in a standardized fashion, in 
which each letter read on a complete line was noted accor-
dingly. Preoperative BCVA, postoperative UCVA, and 
postoperative BCVA were recorded in logMAR units; a 
change of 0.1 unit corresponded to a line of vision.
Lens-power calculations were performed with formulae 
developed by Ophthalmic Innovations International Inc. The 
overall diameter of the phakic IOL to be implanted was 
determined by measuring the WTW diameter with a caliper 
and then adding 1 mm. The target postoperative mean 
refraction (SE) was emmetropia.
Surgical Procedure
Preoperative preparations included administration of 2% 
pilocarpine drops to the operative eye at 15-minute intervals 
and 15% mannitol 300 cc intravenously one hour prior to 
surgery. Nadbath akinesia and retrobulbar anesthesia with 2% 
lidocaine were used. One 1-mm paracentesis was made at the 
3 o’clock position. A small amount of viscoelastic agent 
(Healon
Ⓡ, Pharmacia, Sweden) was injected to maintain a 
stable anterior chamber throughout the surgical procedure. A 
7-mm valved limbal incision was created between the 10 and 
2 o’clock positions with a bevel-up crescent knife. A 7-mm 
lens glide was introduced into the anterior chamber down to 
the 6 o’clock position, taking care to avoid contact with the 
iris, endothelium, and crystalline lens. The viscoelastic agent 
was again injected over the glide sheet. The phakic IOL was 
then introduced toward the 6 o’clock position and the glide 
was withdrawn. The phakic IOL was rotated to the meridian 
in which the pupil was best centered. After the lens had been 
placed in the eye, its stability was tested by pressing on the 
limbus in the meridian of the long axis of the lens to observe 
any unexpected movements or displacements of the lens. A 
peripheral iridectomy was performed using Vannas scissors. 
The incision site was closed with 10-0 nylon-interrupted 
sutures. Before the knot was tied, irrigation of the anterior 
chamber with a balanced salt solution was performed to 
remove any remaining viscoelastic agent. The suture was 
then knotted. Topical ofloxacin ointment was given at the end 
of surgery and the surgical site patched for 24 hours.
Postoperatively, 1% prednisone acetate (Pred Forte
Ⓡ, 
Allergan, USA) and 0.3% Ofloxacin (Tarivid
Ⓡ, Santen, 
Japan) were prescribed. Follow-up examinations were made 
at one day, one week and one, two, three, and six months 
following surgery. ANOVA was used to assess the signifi-
cance of differences among subjects between repeated 
measurements.
The patients’ satisfaction of vision was evaluated at six 
months postoperatively using a questionnaire. Patients were 
asked to subjectively evaluate their level of visual difficulty 
on a 5-point scale in five situations: distance vision, near 
vision, night halo and glare, improvement of working effi-
ciency, and overall satisfaction. Response options were: 1= 
major trouble; 2=a great deal of trouble; 3=moderately 
satisfied; 4=satisfied; 5=very satisfied.
Results
A total of 12 eyes in nine consecutive patients were 
recruited to the study, with six males and three females being 
followed for more than six months. The mean patient age 
was 37.3 years (ranging from 29 to 59 years). The preopera-WK  Sang,  et  al.  PHAKIC  AC  IOLs  IN  HIGH  MYOPIC  AMBLYOPIA
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Eye  No. Preop.  UCVA Preop.  BCVA  (logMAR) Postop.  UCVA  (logMAR) Postop  BCVA  (logMAR)
1
2
3
4
5
6
7
8
9
10
11
12
0.04
0.04
0.02
CF  30  cm
0.04
0.02
0.02
CF  30  cm
CF  30  cm
CF  30  cm
CF  30  cm
CF  30  cm
0.15  (0.8)
0.2  (0.7)
0.15  (0.8)
0.3  (0.5)
0.1  (1.0)
0.2  (0.7)
0.2  (0.7)
0.1  (1.0)
0.2  (0.7)
0.3  (0.5)
0.3  (0.5)
0.15  (0.8)
0.3  (0.5)
0.4  (0.4)
0.3  (0.5)
0.5  (0.3)
0.3  (0.5)
0.5  (0.3)
0.8  (0.1)
0.2  (0.7)
0.3  (0.5)
0.4  (0.4)
0.4  (0.4)
0.4  (0.4)
0.3  (0.5)
0.4  (0.4)
0.4  (0.4)
0.8  (0.1)
0.4  (0.4)
0.5  (0.3)
0.9  (0.05)
0.3  (0.5)
0.4  (0.4)
0.6  (0.2)
0.5  (0.3)
0.4  (0.4)
Mean 0.01 0.20±0.07
(0.73±0.17)
0.40±0.15
(0.42±0.15)
0.49±0.19
(0.33±0.15)
BCVA:  best-corrected  visual  acuity,  CF:  counting  finger,  MAR:  minimum  angle  of  resolution,  UCVA:  uncorrected  visual  acuity.
Table 3. Preoperative  UCVA  and  BCVA  and  6-month  postoperative  UCVA  and  BCVA  in  12  eyes 
Spherical 
(D)
Cylindrical 
(D)
Spherical 
Equivalent  (D)
Preoperative
1  week
1  month
2  months
3  months
6  months
-19.96
-0.95
-1.07
-1.05
-1.10
-1.08
-1.05
-1.59
-1.71
-1.64
-1.59
-1.60
-20.10±5.41
-1.74±0.92
-1.73±0.74
-1.79±0.81
-1.77±0.77
-1.75±0.76
Table 2. Changes  in  manifest  refraction  over  time  in 
patients  with  phakic  anterior  chamber  IOLs  (n=12  eyes)
Fig. 1. Stability of postoperative refraction. Postoperative refraction 
observed  at  1  week  remained  at  1,  2,  3  and  6  months.  (Repeated 
measures  ANOVA  within-subjects;  p=0.83) 
SE=spherical  equivalent.
tive mean UCVA was 0.01 (ranging from CF 30 cm to 0.04), 
and the mean BCVA was 0.18 (ranging from 0.1 to 0.3). The 
preoperative mean refraction (SE) was -20.10±5.41D. The 
mean WTW diameter was 11.2±0.4 mm (ranging from 11 
to 12 mm), the mean overall diameter of the implanted 
phakic IOLs was 12.4±0.5 mm (ranging from 12 to 13 mm), 
and the mean power of phakic IOLs was -18.54±4.34D 
(ranging from -12.5 to -25.0D) (Table 1).
The postoperative mean SE was -1.74±0.92D (ranging 
from -0.625 to -2.375D) at one week and -1.75±0.76D 
Fig. 2. Changes  in  postoperative  BCVA  at  6  months  (12  eyes). 
MAR:  minimum  angle  of  resolution.
(ranging from -1.25 to -2.00D) at six months (Table 2). There 
was no significant change in postoperative SE refraction at 
one week and one, two, three, and six months (p=0.83) (Fig. 
1).
Mean postoperative UCVA was 0.24 (ranging from 0.1 to 
0.6) at one week, 0.34 (ranging from 0.2 to 0.8) at one month 
and 0.40 (ranging from 0.2 to 0.8) at six months. Mean 
postoperative BCVA was 0.39 (ranging from 0.2 to 0.7) at 
one week, 0.44 (ranging from 0.2 to 0.8) at one month and 
0.49 (ranging from 0.3 to 0.9) at six months (Table 3). The 
postoperative BCVA improved an average of 3.92±1.24 
lines (logMAR) compared with the preoperative values at six 
months (Fig. 2).
The preoperative mean endothelial cell density was 3315 
±31 cells/mm
2. After surgery, this decreased to 3128±512 
cells/mm
2 at one month, 3021±609 cells/mm
2 at six months. 
The percentage of endothelial cell loss was 8.9% at six 
months (Fig. 3). The preoperative mean IOP was 14.5±1.83 
mmHg. After surgery, this increased to 17.1±1.85 mmHg at 
one week, and 15.1±2.01 mmHg at six months. None of the 
patients required glaucoma therapy to control IOP elevation Korean  J  Ophthalmol  Vol.20,  No.2,  2006
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Fig. 3. Changes in endothelial cell count following phakic anterior 
c h a m b e r  I O L  i m p l a n t a t i o n .
Fig. 4. Subjective  six-month  postoperative  evaluation  of  quality  of 
vision  in  patients  with  phakic  anterior  chamber  IOLs  operation.
continuously. The preoperative mean anterior chamber depth 
(ACD) was 3.40±0.24 mm. At six months, the mean ACD 
was 3.00±0.33 mm (a 4.1% decrease).
Development of complications such as cataracts, glaucoma, 
chronic uveitis, retinal detachment, endophthalmitis, IOL 
dislocation, and pupil abnormality were not demonstrated in 
any case during the study. The patients were all very satisfied 
and the average satisfaction score was 4.3 (Fig. 4).
Discussion
Refractive correction of very high myopia is a difficult 
clinical problem. At this time, there is no satisfactory surgical 
procedure for the correction of very high myopia. The upper 
limit of correction that can be achieved with radial kerato-
tomy is generally thought to be -8.0D.
16 Although no precise 
limits have been determined, most surgeons do not perform 
LASIK in eyes with myopia higher than -12.0D.
17 PRK has 
generated high expectations for the correction of low and 
moderate myopia. However, keratorefractive surgeries for the 
correction of very high myopia can be problematic because 
of limited predictability and the potential for irreversibility, 
regression, and corneal haze.
6,18 Clear lens extraction followed 
by implantation of low-power IOLs have not gained wide 
acceptance due to complications such as retinal detachment, 
which can lead to early loss of accommodation in relatively 
young patients.
2,4,6
Phakic IOLs are increasingly popular with refractive 
surgeons because of refractive predictability and stability, and 
because they do not alter accommodation.
19 All of the above- 
mentioned reasons support the use of PAC IOLs for the 
correction of refractive errors. However, there are potentially 
important risks that need to be clarified before the procedure 
is put into general use.
One important risk is that angle-supported phakic IOLs 
may induce damage to the anterior chamber structures and 
break-downs in the blood-aqueous barrier. Changes in blood- 
aqueous barrier permeability could induce metabolic lens 
disturbances. These disturbances might accelerate cataract 
development, while anterior chamber inflammation could 
induce corneal endothelium damage and increase intraocular 
pressure.
20 In this study, endothelial cell loss was 8.9% at six 
months and serious endothelial damage did not occur. 
Presently, new models of angle-supported phakic IOLs have 
been modified to avoid these problems; however, long-term 
studies are necessary to assess the potential risks of these 
new models.
The potential for intraocular pressure elevation may be 
related to pupillary block in the early postoperative period, 
with some investigators demonstrating a mean incidence of 
4.8~7.2%.
21,22 It is proposed that the preoperative iridectomy 
contributed to the prevention of intraocular pressure elevation 
in our study.
The pupil-related problems such as iris atrophy, iris 
retraction, pupil ovalization and others may be induced when 
large angle-supported intraocular lenses (compared to patients’ 
corneal diameter) are inserted. Thus, an anterior chamber IOL 
with a flexible haptic is required to prevent these problems.
23 
In our study, iris complications did not occur, although the 
total number of cases in this study was relatively small.
Compared to phakic posterior chamber intraocular lenses, 
the phakic anterior chamber intraocular lens has the 
advantage that glare incidence is lower due to its larger optic. 
However, Phakic 6H
Ⓡ needs further improvement due to 
surveys of patient satisfaction level in which most patients 
did not give above average grades for glare and halo 
symptoms.
Another complication posed by the implantation of a 
phakic IOL is the possibility of inducing cataracts.
4,22 Phakic 
posterior chamber intraocular lenses may contact the crys-
talline lens during accommodation, thus increasing the pos-
sibility of cataract formation.
22,24 Lackner et al.
25 reported 
lens opacification in 11 (14.5%) of 76 myopic eyes, and 
Pineda-Fernandez et al.
3 reported opacification in two 
(11.1%) of 18 very highly-myopic eyes after implantation of 
phakic posterior chamber IOLs.
Amblyopia is a reduction in visual acuity as a result of 
a developmental disorder of spatial vision arising from 
strabismus, anisometropia, or from deprivation early in life.
26 WK  Sang,  et  al.  PHAKIC  AC  IOLs  IN  HIGH  MYOPIC  AMBLYOPIA
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The following are known to cause amblyopia in very 
high-myopia patients: difficulty to fit accurate images on the 
retina through full refractive correction, small image sizes 
due to the lens effect, narrow visual fields, and the possibility 
of manifesting very high order aberrations and so forth.
27 
The visual system is thought to be sensitive to the effects 
of normal experience only during a limited period of time 
early in life, when it is immature and plastic. Accordingly, 
therapy for amblyopia does not offer significant therapeutic 
effects for patients over the age of 10. As such, no clear 
method is suggested today as a therapeutic method for adult 
amblyopia.
28 Generally in the case of very high myopia with 
amblyopia, most use spectacles or contact lenses. 
There have been limited efforts to improve amblyopia in 
adults, even slightly, because of the suspected permanency of 
the deficit. Nevertheless, several reports now describe the 
satisfactory treatment of amblyopia with improvements in 
BCVA in older children and adults.
28-32 Wick et al.
29 and 
Simmers and Gray
30 claim that age is not a critical factor for 
the outbreak of amblyopia therapy, and that conventional 
therapy for amblyopia such as full refractive correction, 
occlusion therapy, prism prescription and so forth can help 
improve visual function in adult amblyopia patients. Sakatani 
et al.
31 and Barequet et al.
32 reported that improvement in 
best corrected visual acuity resulted after performing LASIK 
surgery on adult amblyopia patients. 
I n  t h i s  s t u d y ,  w e  w e r e  a b l e  t o  i m p r o v e  b e s t  c o r r e c t e d  
visual acuity through phakic anterior chamber intraocular lens 
insertion in adult amblyopic eyes with very high myopia. The 
mechanism of refractive surgeries that improves vision is 
considered to be the effect of the magnification of the image 
and refinement at the corneal or lenticular plane rather than 
the spectacle plane.
27,31 According to conventional concepts, 
treatment of adult amblyopia is ineffectual; but by given 
previous reports
28-32 and this study, it is possible to assume 
that numerous patients are classified as amblyopia because 
therapy that may appropriately induce emmetropia has not 
been attempted in them.
This study indicates that angle-supported phakic anterior 
chamber IOL implantation may be an effective surgical 
alternative for the correction of amblyopic adult eyes with 
high myopia. However, long-term evaluation is needed to 
assess possible complications such as cataract, glaucoma, 
endothelial cell loss, and long-term safety.
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